Vir Biotechnology
Focus: Vir Biotechnology is a San Francisco-based biotech focused on infectious disease therapies, spanning viral hepatitis, influenza, HIV, and COVID-19. The company operates as a clinical-stage innovator with a diversified pipeline across multiple modalities.
Profile data last refreshed 2h ago · AI intelligence enriched 2mo ago
Open Jobs
13+2 this month
Stable — net +2 jobs in 30d
7 added, 5 removed. Backfill posture.
Should You Work at Vir Biotechnology?
AI assessmentVir offers infectious disease expertise and clinical development experience, but limited headcount needs and pre-commercialization stage present execution risk.
Why Work Here
- Diversified pipeline with 20 active programs spanning Phase 1-3, providing multiple clinical catalyst opportunities and long-term job security
- Focus on infectious diseases offers mission-driven work in high-unmet-need areas (hepatitis B/D, influenza, HIV, COVID-19)
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Late-stage
5 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Vir Biotechnology
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.